16 studies found for:    Open Studies | Heart Diseases | UCSD OR UC San Diego OR VA San Diego
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | Heart Diseases | UCSD OR UC San Diego OR VA San Diego
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Post-Market CorPath Registry on the CorPath 200 System in Percutaneous Coronary Interventions
Conditions: Coronary Artery Disease;   Coronary Disease;   Myocardial Ischemia;   Heart Diseases;   Cardiovascular Diseases;   Arteriosclerosis;   Arterial Occlusive Diseases;   Vascular Diseases
Intervention: Procedure: CorPath-assisted Percutaneous Coronary Intervention
2 Recruiting Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy
Condition: Transthyretin (TTR) Amyloid Cardiomyopathy
Interventions: Drug: Tafamidis;   Drug: Placebo
3 Recruiting The Dynamics of Human Atrial Fibrillation
Conditions: Atrial Fibrillation;   Atrial Tachyarrhythmia
Intervention:
4 Not yet recruiting Substrate Versus Trigger Ablation for Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Procedure: FIRM Ablation;   Procedure: Conventional AF ablation with PVI
5 Recruiting A Double-Blind Pharmacokinetic Interaction Study Evaluating the Effect of a Single IV Infusion of GGF2 or Placebo on Midazolam Pharmacokinetics in Patients With Heart Failure
Condition: Heart Failure
Interventions: Other: Placebo;   Drug: GGF2;   Drug: Midazolam
6 Unknown  Effect of Ranolazine on Echocardiographic Indices of Diastolic Dysfunction
Conditions: Ranolazine;   Diastolic Heart Failure;   Tissue Doppler Ultrasound;   Echocardiography
Intervention: Drug: ranolazine
7 Recruiting RF Surgical Sponge-Detecting System on the Function of Pacemakers and Implantable Cardioverter Defibrillators
Conditions: Cardiomyopathy;   Cardiac Arrhythmia;   Heart Failure;   Chronic Thromboembolic Pulmonary Hypertension
Intervention: Device: RF Assure Scanning
8 Recruiting Evaluating Myocardial Injury for Defibrillation Threshold Testing Methods for ICD Implantation
Conditions: Cardiomyopathy;   Heart Failure;   Cardiac Arrhythmia
Interventions: Device: Standard Defibrillation Threshold (DFT) Testing;   Device: Upper Limit of Vulnerability (ULV) Testing
9 Recruiting AV Delay Optimization vs. Intrinsic Conduction in Pacemaker Patients With Long PR Intervals
Conditions: Atrioventricular Block;   Sick Sinus Syndrome;   Symptomatic Bradycardia;   Cardiac Arrhythmia
Interventions: Device: Long, fixed AV delay;   Device: Short, optimized AV delay
10 Recruiting Nit-Occlud PDA Post-Approval Study
Condition: Patent Ductus Arteriosus (PDA)
Intervention:
11 Recruiting ZIPS Study - Zip Incision aPproximation vs. Suture
Conditions: Surgical Wound Closure;   Cardiac Arrhythmia
Interventions: Device: Zip Surgical Skin Closure Device;   Device: Standard Suture Closure
12 Recruiting Effectiveness Study of Circumferential vs. Segmental Ablation in Paroxysmal Atrial Fibrillation
Conditions: Paroxysmal Atrial Fibrillation;   Atrial Arrhythmia
Interventions: Procedure: Circumferential Pulmonary Vein Ablation (CPVA);   Procedure: Segmental Pulmonary Vein Isolation (SPVI)
13 Recruiting Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia
Condition: Cardiac Arrest
Interventions: Drug: amiodarone;   Drug: Lidocaine;   Other: Normal saline
14 Recruiting MAESTRO (Macitentan in Eisenmenger Syndrome To Restore Exercise Capacity)
Condition: Eisenmenger Syndrome
Interventions: Drug: Macitentan 10 mg, oral tablet, to be taken once daily.;   Drug: Matching placebo oral tablet, to be taken once daily.
15 Recruiting Cardiovascular Inflammation Reduction Trial
Condition: Cardiovascular Disease
Interventions: Drug: Methotrexate;   Drug: Placebo
16 Recruiting Ambrisentan in Patients With Porto-pulmonary Hypertension A Multicenter Open Label Trial
Condition: Portopulmonary Hypertension
Intervention: Drug: Ambrisentan

Indicates status has not been verified in more than two years